QA: Chemours Co in us_medicinal_products/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001627223_2023_Chemours_Co.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001627223, Chemours Co

  xvar xval
0 LiabilitiesNoncurrent 4,581,000,000
1 LiabilitiesCurrent 1,952,000,000
2 remainder_Liabilities 0
3 AssetsCurrent 3,214,000,000
4 AssetsNoncurrent 938,000,000
5 PropertyPlantAndEquipmentNet 3,171,000,000
6 Goodwill 102,000,000
7 remainder_Assets 215,000,000
8 GeneralAndAdministrativeExpense 5,888,000,000
9 ResearchAndDevelopmentExpense 118,000,000
10 remainder_Expenses 342,000,000
11 remainder_Revenues 6,794,000,000
12 remainder_NetIncome 132,000,000
13 remainder_ComprehensiveNetIncome 21,000,000
  yvar yval
0 Liabilities 6,533,000,000
1 Assets 7,640,000,000
2 Expenses 6,348,000,000
3 Revenues 6,794,000,000
4 StockholdersEquity 1,107,000,000
5 NetIncome 578,000,000
6 ComprehensiveNetIncome 588,500,000
7 BaseVar 13,734,000,000
8 EconomicCapitalRatio 0.216

Edgar->Model Mapping

Feature Distribution

Change over Time